Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Eleanor Stride (Department of Engineering Science and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science) has taken an unconventional path to becoming one of Britain’s leading scientists. In a new Oxford Science Blog, she tells Sarah Whitebloom how she moved from dance to design and onto biomedical science, but being a 'woman in science' is not one of the identities she seeks.

Professor Eleanor Stride © New York Academy of Sciences/ Blavatnik Awards for Young Scientists

When is a woman in science not a ‘woman in science’? When she is a woman in science.

At the risk of generalisation, women in science are hard-working, dedicated, cutting edge…scientists.  Call them ‘women in science’ at your peril.  Women in science will tell you quite firmly that they do not want to be treated differently or feel they do not deserve their place. Any hint of tokenism will be greeted with a frosty response. 

And Professor Eleanor Stride is an uber scientist, which is nothing to do with mini-cabs but everything to do with dedication, hard-work and world-changing ideas.  It is hard to imagine that she has ever felt she is making up the numbers.

‘You’d be surprised,’ she says. Sometimes, it is felt that there has to be a woman involved and no one wants to be that woman.  Professor Stride maintains there is, of course, a need for more women in science and is infuriated at the idea that girls are still told that Maths and science is not for them. She is, quite literally, furious at the ‘Mummy wasn’t any good at Maths’, sort of parental advice. And, she says, the counter-balance needs to start early, at Primary School, when girls start to drift away from the sciences and Maths.

Read the full blog on the University of Oxford website

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.